Related Experiment Videos
Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization
John C Mullen1, Michael J Bentley, Elliot T Gelfand
1Division of Cardiac Surgery, The University of Alberta, Edmonton. jmullen@ualberta.ca
Insights
Heparin-coated cardiopulmonary bypass circuits with low-dose heparinization are safe for coronary artery bypass grafting but offer no significant advantages over standard methods in terms of bleeding or outcomes.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Anesthesiology
Background:
- Coronary artery bypass grafting (CABG) commonly utilizes cardiopulmonary bypass (CPB).
- Standard CPB involves uncoated circuits and full heparinization, posing risks of bleeding and requiring transfusions.
- Heparin-coated circuits and centrifugal pumps aim to improve safety and reduce anticoagulation needs.
Purpose of the Study:
- To compare the safety and efficacy of heparin-coated CPB circuits with low-dose heparinization and centrifugal pumping against standard CPB during CABG.
- To evaluate postoperative bleeding, transfusion requirements, and clinical outcomes.
Main Methods:
- Prospective, randomized, single-blind clinical trial involving 90 patients undergoing elective CABG.
- Three groups: standard uncoated circuit with roller pump and full heparinization; heparin-coated oxygenator with centrifugal pump and full heparinization; fully heparin-coated circuit with centrifugal pump and low heparinization.
- Outcomes assessed included postoperative bleeding, transfusion needs, and clinical events.
Main Results:
- No study-related complications were reported across all groups.
- Postoperative bleeding, transfusion requirements, and clinical outcomes were comparable among the three groups.
- The heparin-coated CPB with low-dose heparinization and centrifugal pump demonstrated similar safety and efficacy to standard CPB.
Conclusions:
- Heparin-coated cardiopulmonary bypass with low-dose heparinization and centrifugal pumping is a safe approach for CABG.
- This advanced technique did not show superior benefits compared to conventional uncoated bypass circuits in terms of bleeding or clinical outcomes.
- Further research may be needed to identify specific patient populations or procedural variations where heparin-coated circuits offer a distinct advantage.
Objective:
To evaluate the safety and efficacy of heparin-coated perfusion circuits with low-dose heparinization and centrifugal pumping compared with the standard method during coronary artery bypass grafting.
Design:
Prospective, randomized, single-blind clinical trial.
Setting:
A primary care institution.
Patients:
Ninety patients who underwent first-time elective coronary artery bypass grafting were eligible for the study. After giving informed consent, they were randomly assigned to 1 of 3 groups (30/group).
Interventions:
Perfusion on regular uncoated bypass equipment with a roller pump and full-dose heparinization (300 IU/kg bolus, activated clotting time [ACT] > 400 s) (group 1), on a heparin-coated oxygenator with a centrifugal pump and full-dose heparinization (group 2) and on fully heparin-coated bypass equipment with a centrifugal pump and low-dose heparinization (100 IU/kg bolus, ACT of 180-400 s) (group 3). Standard coronary artery bypass grafting was performed.
Outcome Measures:
Postoperative bleeding, transfusion requirements and clinical outcomes.
Results:
There were no complications related to the study protocol. Study groups were similar in terms of postoperative bleeding, transfusion requirements and clinical outcomes.
Conclusions:
Heparin-coated cardiopulmonary bypass with low-dose heparinization and centrifugal pumping is a safe practice but showed no advantages over the use of regular uncoated bypass circuits for coronary bypass surgery.